University of California San Francisco

Jaeyun (Jane) Wang
Jaeyun (Jane)
Wang
MD

Resident (PGY-4)
General Surgery

    Education

    Institution Degree Dept or School End Date
    Johns Hopkins University School of Medicine MD 05/2019
    Northwestern University BA Biological Sciences 06/2014
    University of California, San Francisco Residency

    Awards & Honors

    Award Conferred By Date
    Recognition of Excellence Coin Society of American Gastrointestinal and Endoscopic Surgeons 2024
    Top 10 Residents/Fellows Best Presentation Competition (2nd Place) Society of American Gastrointestinal and Endoscopic Surgeons 2024
    Department of Surgery 37th Annual Research Symposium: Best Presentation in Clinical Research University of California, San Francisco 2024
    Surgical Data Science Project Winner IHU-Strasbourg 2023
    Muriel Steele Society Influential Women in Surgery Honor Roll University of California, San Francisco 2022
    Noyce Initiative Computational Innovator Postdoctoral Fellowship Award University of California, San Francisco 2021
    Alpha Omega Alpha Johns Hopkins University School of Medicine 2019
    Summa Cum Laude Northwestern University 2014

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 67
    1. Is Laterality Prognostic in Resected KRAS-Mutated Colorectal Liver Metastases? A Systematic Review and Meta-Analysis.
      Belias M, Sasaki K, Wang J, Andreatos N, Kamphues C, Kyriakos G, Seeliger H, Beyer K, Kreis ME, Margonis GA| | PubMed
    2. Using the Comprehensive Complication Index to Rethink the ISGLS Criteria for Post-hepatectomy Liver Failure in an International Cohort of Major Hepatectomies.
      Calthorpe L, Rashidian N, Cacciaguerra AB, Conroy PC, Hibi T, Hilal MA, Hoffman D, Park KM, Wang J, Adam MA, Alseidi A, International Post-Hepatectomy Liver Failure Study Group| | PubMed
    3. Performance of the 7 th and 8 th Editions of the American Joint Committee on Cancer Staging System in Patients with Intraductal Papillary Mucinous Neoplasm-Associated PDAC : A Multi-institutional Analysis.
      Margonis GA, Pulvirenti A, Morales-Oyarvide V, Buettner S, Andreatos N, Kamphues C, Beyer K, Wang J, Kreis ME, Cameron JL, Weiss MJ, Soares K, Fernández-Del Castillo C, Allen PJ, Wolfgang CL| | PubMed
    4. Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?
      Amini N, Andreatos N, Margonis GA, Buettner S, Wang J, Galjart B, Wagner D, Sasaki K, Angelou A, Sun J, Kamphues C, Beer A, Morioka D, Løes IM, Antoniou E, Imai K, Pikoulis E, He J, Kaczirek K, Poultsides G, Verhoef C, Lønning PE, Endo I, Baba H, Kornprat P, NAucejo F, Kreis ME, Christopher WL, Weiss MJ, Safar B, Burkhart RA| | PubMed
    5. Reevaluating the prognostic role of BRAF mutation in colorectal cancer liver metastases.
      Pikouli A, Papaconstantinou D, Wang J, Kavezou F, Pararas N, Nastos C, Pikoulis E, Margonis GA| | PubMed
    6. Reevaluating the prognostic value of RAS mutation status in patients with resected liver metastases from colorectal cancer: A systematic review and meta-analysis.
      Pikoulis E, Papaconstantinou D, Pikouli A, Wang J, Theodoridis C, Margonis GA| | PubMed
    7. Designing an Intimate Partner Violence Screening Program for Surgical Residents in Trauma
      Decker H, Schwab ME, Wang J, Rosser ML, Petersen V, Berger M, Stein DM, Bongiovanni T| | UCSF Research Profile
    8. The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.
      Margonis GA, Amini N, Buettner S, Kim Y, Wang J, Andreatos N, Wagner D, Sasaki K, Beer A, Kamphues C, Morioka D, Løes IM, Imai K, He J, Pawlik TM, Kaczirek K, Poultsides G, Lønning PE, Burkhart R, Endo I, Baba H, Mischinger HJ, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ| | PubMed
    9. Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH-MSK scores.
      Sasaki K, Gagnière J, Dupré A, Ardiles V, O'Connor JM, Wang J, Moro A, Morioka D, Buettner S, Gau L, Ribeiro M, Wagner D, Andreatos N, Løes IM, Fitschek F, Kaczirek K, Lønning PE, Kornprat P, Poultsides G, Kamphues C, Imai K, Baba H, Endo I, Kwon CHD, Aucejo FN, de Santibañes E, Kreis ME, Margonis GA| | PubMed
    10. The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study.
      Kamphues C, Andreatos N, Kruppa J, Buettner S, Wang J, Sasaki K, Wagner D, Morioka D, Fitschek F, Løes IM, Imai K, Sun J, Poultsides G, Kaczirek K, Lønning PE, Endo I, Baba H, Kornprat P, Aucejo FN, Wolfgang CL, Kreis ME, Weiss MJ, Margonis GA| | PubMed